Daily Record of Severity of Problems (DRSP): reliability and validity.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 16172836)

Published in Arch Womens Ment Health on September 20, 2005

Authors

J Endicott1, J Nee, W Harrison

Author Affiliations

1: Department of Research Assessment and Training, New York State Psychiatric Institute, New York 10032, USA.

Associated clinical trials:

Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome (PMS) | NCT02089620

Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome | NCT02488538

Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome | NCT02427334

Premenstrual Syndrome Etiology Pilot Study (PMSe-Pilot) | NCT03862469

Articles citing this

Premenstrual syndrome. Lancet (2008) 2.92

Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci (2008) 1.22

Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry (2009) 1.14

Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health (2011) 1.09

Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology (2007) 1.08

Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences. Biol Psychol (2010) 0.94

Menstrual cycle-related exacerbation of disease. Am J Obstet Gynecol (2010) 0.93

Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biol Psychiatry (2010) 0.91

Clinical subtypes of premenstrual syndrome and responses to sertraline treatment. Obstet Gynecol (2011) 0.91

Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep (2015) 0.91

ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health (2013) 0.89

Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study. Am J Psychiatry (2013) 0.89

Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial. JAMA Psychiatry (2015) 0.88

Perceived stress and severity of perimenstrual symptoms: the BioCycle Study. J Womens Health (Larchmt) (2010) 0.88

Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS). Am J Psychiatry (2016) 0.83

Hypothalamic-pituitary-thyroid axis function in women with a menstrually related mood disorder: association with histories of sexual abuse. Psychosom Med (2012) 0.83

Core symptoms that discriminate premenstrual syndrome. J Womens Health (Larchmt) (2010) 0.83

Menstrual mood disorders are associated with blunted sympathetic reactivity to stress. J Psychosom Res (2013) 0.81

Prefrontal brain asymmetry and pre-menstrual dysphoric disorder symptomatology. J Affect Disord (2010) 0.80

Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder. Psychoneuroendocrinology (2016) 0.79

The association of migraine with menstrually related mood disorders and childhood sexual abuse. J Womens Health (Larchmt) (2013) 0.79

Selective serotonin reuptake inhibitors and endothelial function in women. J Womens Health (Larchmt) (2014) 0.79

The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO(2) challenge. Arch Womens Ment Health (2012) 0.77

Mindfulness-based Stress Reduction as a Promising Intervention for Amelioration of Premenstrual Dysphoric Disorder Symptoms. Mindfulness (N Y) (2015) 0.77

Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder. Eur Arch Psychiatry Clin Neurosci (2013) 0.76

The association of dysmenorrhea with noncyclic pelvic pain accounting for psychological factors. Am J Obstet Gynecol (2013) 0.76

Depressive symptoms and their relationship with endogenous reproductive hormones and sporadic anovulation in premenopausal women. Ann Epidemiol (2014) 0.76

Elevated gray matter volume of the emotional cerebellum in women with premenstrual dysphoric disorder. J Affect Disord (2012) 0.76

The influence of early life sexual abuse on oxytocin concentrations and premenstrual symptomatology in women with a menstrually related mood disorder. Biol Psychol (2015) 0.75

Making Strides to Simplify Diagnosis of Premenstrual Dysphoric Disorder. Am J Psychiatry (2017) 0.75

Emotion regulation in women with premenstrual dysphoric disorder. Arch Womens Ment Health (2016) 0.75

The Effects of Sertraline in Controlling Refractory Hypertension in Women with Premenstrual Syndrome. Iran J Psychiatry (2016) 0.75

Treating comorbid premenstrual dysphoric disorder in women with bipolar disorder. J Psychiatry Neurosci (2016) 0.75

Effect of Group Cognitive-Behavioral Therapy on Health-Related Quality of Life in Females With Premenstrual Syndrome. Iran J Psychiatry Behav Sci (2016) 0.75

Abnormal Spontaneous Brain Activity in Women with Premenstrual Syndrome Revealed by Regional Homogeneity. Front Hum Neurosci (2017) 0.75

Personal history of major depression may put women at risk for premenstrual dysphoric symptomatology. J Affect Disord (2013) 0.75

Lack of association of DRD3 and CNR1 polymorphisms with premenstrual dysphoric disorders. Iran J Reprod Med (2015) 0.75

Anxiety Disorders Among Women: A Female Lifespan Approach. Focus (Am Psychiatr Publ) (2017) 0.75

Study Protocol for a Randomized Double Blind, Treatment Control Trial Comparing the Efficacy of a Micronutrient Formula to a Single Vitamin Supplement in the Treatment of Premenstrual Syndrome. Medicines (Basel) (2016) 0.75

Articles by these authors

Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull (1993) 7.03

Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48

Modifier role of internal H+ in activating the Na+-H+ exchanger in renal microvillus membrane vesicles. Nature (1982) 3.49

A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology (2003) 3.14

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA (1997) 3.08

Heterogeneity of clinical response during placebo treatment. Am J Psychiatry (1991) 2.06

Treatment of premenstrual depression with nortriptyline: a pilot study. J Clin Psychiatry (1989) 1.93

Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouse. Nat Genet (1998) 1.83

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry (1996) 1.71

Hamilton Depression Rating Scale. Extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry (1981) 1.68

Gender differences in chronic major and double depression. J Affect Disord (2000) 1.53

Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality. Am J Psychiatry (2000) 1.52

Sclerosing sweat duct carcinoma of the eyelid margin: unusual presentation of a rare tumor. Ophthalmology (1999) 1.49

Use of pattern analysis to identify true drug response. A replication. Arch Gen Psychiatry (1987) 1.48

Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry (2004) 1.46

Interaction of external H+ with the Na+-H+ exchanger in renal microvillus membrane vesicles. J Biol Chem (1983) 1.41

The inclusion of women in psychopharmacologic trials. J Clin Psychopharmacol (1993) 1.40

Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry (1993) 1.40

Different types of placebo response in patients receiving antidepressants. Am J Psychiatry (1991) 1.40

Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull (1997) 1.39

Enumeration of byssochlamys and other heat-resistant molds. Appl Microbiol (1970) 1.36

Human sympathetic ophthalmia. An analysis of the inflammatory infiltrate by hybridoma-monoclonal antibodies, immunochemistry, and correlative electron microscopy. Ophthalmology (1983) 1.35

DSM-III field trials: I. Initial interrater diagnostic reliability. Am J Psychiatry (1979) 1.34

Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Br J Psychiatry Suppl (1993) 1.26

Diagnostic criteria for schizophrenia: reliabilities and agreement between systems. Arch Gen Psychiatry (1982) 1.16

How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry Res (1986) 1.15

Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry (2006) 1.14

Alveolar soft-part sarcoma. Thorax (1982) 1.10

Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone. J Infect Dis (1997) 1.09

A cluster randomised controlled trial of a web based decision aid to support parents' decisions about their child's Measles Mumps and Rubella (MMR) vaccination. Vaccine (2013) 1.08

Phenelzine v imipramine in atypical depression. A preliminary report. Arch Gen Psychiatry (1984) 1.04

Phenelzine-induced pyridoxine deficiency. J Clin Psychopharmacol (1984) 1.04

Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin. Ophthalmology (1986) 1.03

Premenstrual changes and affective disorders. Psychosom Med (1981) 1.03

Bipolar II. Combine or keep separate? J Affect Disord (1985) 1.01

Amyloidosis in ankylosing spondylitis. Rheumatol Phys Med (1971) 1.00

The effect of music and exercise upon the self-help skills of non-verbal retardates. Am J Ment Defic (1966) 0.98

L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism. Life Sci (1969) 0.97

Success of the Fasanella-Servat operation independent of Müller's smooth muscle excision. Ophthalmology (1989) 0.97

Intravascular papillary endothelial hyperplasia: collection of four cases and a review of the literature. Ophthal Plast Reconstr Surg (1997) 0.96

Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J Clin Psychopharmacol (1994) 0.95

Non-invasive model-based estimation of aortic pulse pressure using suprasystolic brachial pressure waveforms. J Biomech (2009) 0.95

Reliability and relationship of various ages of onset criteria for major affective disorder. J Affect Disord (1987) 0.95

Itraconazole in the treatment of orbital aspergillosis. Ophthalmology (1996) 0.95

Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers. J Clin Psychopharmacol (1997) 0.94

Study duration in antidepressant research: advantages of a 12-week trial. J Psychiatr Res (1986) 0.93

Clinical and molecular evaluation of four patients with partial duplications of the long arm of chromosome 18. Am J Hum Genet (1993) 0.92

Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. Arch Gen Psychiatry (1990) 0.91

Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo. Arch Gen Psychiatry (1989) 0.90

Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety (2001) 0.90

Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design. Arch Gen Psychiatry (1991) 0.90

Lack of C/EBP alpha gene expression results in increased DNA synthesis and an increased frequency of immortalization of freshly isolated mice [correction of rat] hepatocytes. Hepatology (1998) 0.90

An internist joins the surgery service: does comanagement make a difference? J Gen Intern Med (1994) 0.90

Duration of antidepressant trials: clinical and research implications. J Clin Psychopharmacol (1994) 0.90

Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness. Am J Psychiatry (1994) 0.90

"Retinal anlage" tumors. Melanotic progonoma, melanotic adamantinoma, pigmented epulis, melanotic neuroectodermal tumor of infancy, benign melanotic tumor of infancy. Am J Clin Pathol (1969) 0.89

Clinical and computed tomographic characteristics of amyloid tumor of the lacrimal gland. Ophthalmology (1996) 0.89

Premenstrual changes: patterns and correlates of daily ratings. J Affect Disord (1986) 0.88

Chronic depression: response to placebo, imipramine, and phenelzine. J Clin Psychopharmacol (1993) 0.88

An empirical definition of "primary care". J Community Health (1980) 0.87

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression. Arch Gen Psychiatry (1989) 0.87

Case report of carpal tunnel syndrome associated with tranylcypromine. Am J Psychiatry (1983) 0.86

Interstitial deletions are not the main mechanism leading to 18q deletions. Am J Hum Genet (1994) 0.86

YAC rescue of downless locus mutations in mice. Mamm Genome (1998) 0.85

Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry (1995) 0.85

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry (2000) 0.85

Treatment of premenstrual dysphoric changes: clinical outcome and methodological implications. Psychopharmacol Bull (1984) 0.85

An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. Am Heart J (1999) 0.85

Fetal bovine bone cells synthesize bone-specific matrix proteins. J Cell Biol (1984) 0.85

Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study. J Clin Psychopharmacol (1984) 0.85

Molecular mapping of the Edwards syndrome phenotype to two noncontiguous regions on chromosome 18. Am J Hum Genet (1994) 0.85

Genomic DNA sequence, promoter expression, and chromosomal mapping of rat muscle carnitine palmitoyltransferase I. Genomics (1998) 0.84

Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol Bull (1995) 0.84

Primary infiltrating signet ring carcinoma of the eyelids. Ophthalmology (1983) 0.84

Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res (1989) 0.84

Sleep of atypical depressives. J Affect Disord (1985) 0.83

Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant. Psychopharmacol Bull (1987) 0.82

Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand (1986) 0.82

Premenstrual depressive changes. Value of differentiation. Arch Gen Psychiatry (1983) 0.82

The X-linked mouse mutation Bent tail is associated with a deletion of the Zic3 locus. Hum Mol Genet (2000) 0.82

Treatment of premenstrual dysphoria with alprazolam. A controlled study. Arch Gen Psychiatry (1990) 0.82

Incidence of heat-resistant molds in eastern orchards and vineyards. Appl Microbiol (1971) 0.82

Syringocystadenoma papilliferum of the eyelid. Ophthalmology (1981) 0.81

Brief vs standard hospitalization: for whom? Arch Gen Psychiatry (1979) 0.81

Low nicotine cigarettes: cigarette consumption and breath carbon monoxide after one year. Clin Pharmacol Ther (1983) 0.81

Defining the boundaries of atypical depression. J Clin Psychiatry (1984) 0.81

Correlation of high-frequency ultrasound backscatter with tumor microstructure in iris melanoma. Ophthalmology (1998) 0.81

Phenelzine for chronic depression: a study of continuation treatment. J Clin Psychiatry (1986) 0.81

Structure activity hypotheses in occupational asthma caused by low molecular weight substances. Ann Occup Hyg (1991) 0.81

A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis. Aust N Z J Med (1991) 0.79

Baseline characteristics of 10-day placebo washout responders in antidepressant trials. Psychiatry Res (1987) 0.79

Keratophakia and keratomileusis: comparison of pathologic features in penetrating keratoplasty specimens. Ophthalmology (1981) 0.79

Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand (1990) 0.79

Follow-up of patients who improved during placebo washout. J Clin Psychopharmacol (1986) 0.79

Patch testing of coolant fractions. J Occup Med (1975) 0.79

The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr Scand (1982) 0.79

Metastatic Merkel cell carcinoma to the eye. Ophthalmology (1991) 0.79

A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin, and placebo. J Clin Psychopharmacol (1987) 0.78

Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression. Arch Gen Psychiatry (1985) 0.78